Adherium Limited (ADR.AX)
AUD 0.01
(9.09%)
AUD 0.01
(9.09%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 93.2 Thousand AUD | 111.83% |
| 2023 | 44 Thousand AUD | -48.24% |
| 2022 | 85 Thousand AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | -100.0% |
| 2015 | 1.5 Million AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 93.2 Thousand AUD | 111.83% |
| 2024 Q2 | 20.73 Thousand AUD | 0.0% |
| 2024 Q4 | 93.2 Thousand AUD | 0.0% |
| 2023 Q4 | 44 Thousand AUD | 0.0% |
| 2023 Q2 | 67 Thousand AUD | 0.0% |
| 2023 FY | 44 Thousand AUD | -48.24% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 Q4 | 85 Thousand AUD | 0.0% |
| 2022 FY | 85 Thousand AUD | 0.0% |
| 2021 Q2 | 3.28 Million AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| 2020 Q2 | 3.87 Million AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | -100.0% |
| 2015 FY | 1.5 Million AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 98.18% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 98.633% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -10.08% |
| Anteris Technologies Ltd | 2.33 Million AUD | 96.005% |
| Control Bionics Limited | 961.73 Thousand AUD | 90.309% |
| CardieX Limited | 3.22 Million AUD | 97.112% |
| Compumedics Limited | 6.97 Million AUD | 98.664% |
| Cochlear Limited | 243.7 Million AUD | 99.962% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 97.296% |
| Cyclopharm Limited | 4.22 Million AUD | 97.795% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 96.786% |
| Nova Eye Medical Limited | 3.34 Million AUD | 97.217% |
| HeraMED Limited | 260.65 Thousand AUD | 64.242% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 99.406% |
| ImpediMed Limited | 1.14 Million AUD | 91.846% |
| InhaleRx Limited | 560.27 Thousand AUD | 83.364% |
| LBT Innovations Limited | 1.74 Million AUD | 94.653% |
| Micro-X Limited | 4.05 Million AUD | 97.701% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -31.884% |
| PolyNovo Limited | 15.38 Million AUD | 99.394% |
| Respiri Limited | 1.17 Million AUD | 92.078% |
| SomnoMed Limited | 1.01 Million AUD | 90.826% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 98.125% |
| Uscom Limited | 989.27 Thousand AUD | 90.578% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | 70.142% |